Final Overall Survival Analysis of the Phase III Randomized Trial of Chemotherapy with and Without Bevacizumab for Advanced Cervical Cancer: a Nrg Oncology - Gynecologic Oncology Group Study

Journal article

Open access

Peer reviewed

K.S. Tewari, M.W. Sill, R.T. Penson, H. Huang, L.M. Ramondetta, L.M. Landrum, A. Oaknin, T.J. Reid, M.M. Leitao, B.J. Monk, …

Annals of oncology, Vol.25, p.v1

09/2014

Files and links (1)

url

https://doi.org/10.1093/annonc/mdu438.27View

Published (Version of record) Open

4 Record Views

Title: Final Overall Survival Analysis of the Phase III Randomized Trial of Chemotherapy with and Without Bevacizumab for Advanced Cervical Cancer: a Nrg Oncology - Gynecologic Oncology Group Study
Creators: K.S. Tewari - University of California, Irvine Medical Center
M.W. Sill - Roswell Park Cancer Institute
R.T. Penson - Massachusetts General Hospital
H. Huang - Roswell Park Cancer Institute
L.M. Ramondetta - Anderson Hospital
L.M. Landrum - Oklahoma City University
A. Oaknin - Hebron University
T.J. Reid - University of Cincinnati
M.M. Leitao - Memorial Sloan Kettering Cancer Center
B.J. Monk - St. Joseph's Hospital and Medical Center
H.E. Michael - Indiana University – Purdue University Indianapolis
Publication Details: Annals of oncology, Vol.25, p.v1
Identifiers: 991005968783802656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article